type 1 diabetes

Study team members Stephan Ramos, Seung Kim, and Preksha Bhagchandani – credit, Steve Fisch, Stanford UniversityIn an experiment that exceeded scientists’ expectations, mice had their type-1 diabetes cured through a double-transplant method. Additionally, there was no host rejection of one one of the two types of transplanted cells, and the immune system didn’t attack the […]

by University of Chicago Medical Center edited by Lisa Lock, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Credit: Cell Reports Medicine (2026). DOI: 10.1016/j.xcrm.2026.102634 Research on preventing type 1 diabetes often focuses on limiting the autoimmune response that destroys the body’s ability to produce its own insulin. A new technology developed by scientists at the

By Garvan Institute of Medical ResearchMarch 1, 20264 Comments6 Mins Read A widely used, low-cost drug may be poised to reshape how type 1 diabetes is managed. In a carefully controlled clinical trial, researchers discovered that while the medication doesn’t work in the way many assumed, it still delivers a meaningful benefit: reducing the amount of

by Bill Levesque, University of Florida edited by Lisa Lock, reviewed by Andrew Zinin  Editors’ notes This is a microscopic view of islets of insulin-producing beta cells from a human pancreas, shown using immunofluorescent staining. The islets are green. Credit: Clive Wasserfall and Denise Drotar Type 1 diabetes is a disease in which the body mistakenly attacks itself

by Garvan Institute of Medical Research edited by Gaby Clark, reviewed by Robert Egan  Editors’ notes Credit: Artem Podrez from Pexels A Garvan-led clinical trial has found that using a common and inexpensive type 2 diabetes drug reduces insulin needs in type 1 diabetes, opening doors for improved management of the condition. For years, doctors have prescribed metformin,

by Louise Vennells, University of Exeter edited by Lisa Lock, reviewed by Robert Egan  Editors’ notes AI-assisted WSI analysis performed to investigate the development of the endocrine architecture postbirth during pancreas expansion. Credit: Science Advances (2025). DOI: 10.1126/sciadv.adz2251 Scientists have made a major breakthrough in understanding why type 1 diabetes is more aggressive in young children, offering the clearest explanation